NATIONAL HEALTHCARE CORP Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain
NATIONAL HEALTHCARE CORP (NHC) reported Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-16.
Discontinued › Income Statement › Other Income
us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain · last filed 2024-02-16
- NATIONAL HEALTHCARE CORP business combination, step acquisition, equity interest in acquiree, remeasurement gain for the quarter ending 2022-12-31 was $0.00.
- NATIONAL HEALTHCARE CORP business combination, step acquisition, equity interest in acquiree, remeasurement gain for the quarter ending 2022-09-30 was $0.00.
- NATIONAL HEALTHCARE CORP business combination, step acquisition, equity interest in acquiree, remeasurement gain for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- NATIONAL HEALTHCARE CORP business combination, step acquisition, equity interest in acquiree, remeasurement gain for the quarter ending 2021-12-31 was $0.00.
- NATIONAL HEALTHCARE CORP business combination, step acquisition, equity interest in acquiree, remeasurement gain for fiscal 2023 was $0.00.
- NATIONAL HEALTHCARE CORP business combination, step acquisition, equity interest in acquiree, remeasurement gain for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- NATIONAL HEALTHCARE CORP business combination, step acquisition, equity interest in acquiree, remeasurement gain for fiscal 2021 was $95.20M, a 5477.15% increase from fiscal 2020.
- NATIONAL HEALTHCARE CORP business combination, step acquisition, equity interest in acquiree, remeasurement gain for fiscal 2020 was $1.71M, a 13.57% decline from fiscal 2019.
| Period end | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain 3 month | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain 6 month | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain 9 month | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-16 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $0.00 derived: sum of 2 quarters · filed 2024-02-16 | $0.00 derived: sum of 3 quarters · filed 2024-02-16 | $0.00 10-K · filed 2024-02-16 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-04 | $0.00 10-Q · filed 2022-08-04 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $0.00 derived: sum of 2 quarters · filed 2024-02-16 | $95.20M derived: sum of 3 quarters · filed 2024-02-16 | $95.20M 10-K · filed 2024-02-16 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-03 | $95.20M derived: sum of 2 quarters · filed 2022-11-03 | $95.20M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $95.20M 10-Q · filed 2022-08-04 | $95.20M 10-Q · filed 2022-08-04 | ||
| 2020-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | -$1.00K derived: sum of 2 quarters · filed 2023-02-17 | -$1.00K derived: sum of 3 quarters · filed 2023-02-17 | $1.71M 10-K · filed 2023-02-17 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | $1.71M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-05 | $1.71M 10-Q · filed 2021-08-05 | ||
| 2019-12-31 | $1.98M 10-K · filed 2022-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACS Group, Inc. (PACS) | United States | $6.566B | 25.08 |
| ENSIGN GROUP, INC (ENSG) | United States | $10.098B | 24.68 |